Canopy Growth(US:CGC) ZACKSยท2025-06-23 23:01Company Performance - Canopy Growth Corporation (CGC) closed at $1.19, down 4.03% from the previous trading session, underperforming the S&P 500's gain of 0.96% [1] - The stock has decreased by 32.24% over the past month, contrasting with the Medical sector's loss of 0.85% and the S&P 500's gain of 0.5% [1] Earnings Projections - The upcoming earnings report is projected to show an earnings per share (EPS) of -$0.1, which represents a 72.97% increase from the same quarter last year [2] - Revenue is anticipated to be $48.08 million, indicating a 0.64% decrease from the same quarter last year [2] Full Year Estimates - For the full year, earnings are projected at -$0.41 per share and revenue at $199.33 million, reflecting changes of +86.24% and +3.12% respectively from the previous year [3] - Recent analyst estimate revisions suggest a positive outlook for the company's business and profitability [3] Analyst Ratings - The Zacks Rank system, which ranges from 1 (Strong Buy) to 5 (Strong Sell), currently rates Canopy Growth Corporation at 3 (Hold) [5] - The consensus EPS projection has increased by 22.27% in the past 30 days, indicating some analyst optimism [5] Industry Context - The Medical - Products industry, part of the Medical sector, holds a Zacks Industry Rank of 164, placing it in the bottom 34% of over 250 industries [6] - The Zacks Industry Rank measures the strength of industry groups based on the average Zacks Rank of individual stocks, with the top 50% rated industries outperforming the bottom half by a factor of 2 to 1 [6]